The New York Stock Exchange is seen in New York, Monday, Nov. 23, 2020. Stocks were mostly lower in early trading Thursday, May 6, 2021. Healthcare stocks were among the biggest decliners after news last night that the White House supports waiving intellectual property rights for coronavirus vaccines to help immunize poorer countries faster. (AP Photo/Seth Wenig, File) A woman wearing a protective mask rides a bicycle in front of an electronic stock board showing Japan's Nikkei 225 index at a securities firm Thursday, May 6, 2021, in Tokyo. Asian shares were mixed Thursday on cautious optimism about upcoming company earnings reports showing some recovery from the damage of the coronavirus pandemic. (AP Photo/Eugene Hoshiko)
Stocks rose in afternoon trading Thursday, as gains by technology companies offset falling healthcare stocks.
Investors are still digesting the latest corporate earnings and turning their attention to job growth as the the U.S. pushes on with its economic recovery. Job growth has been one of the keys to a sustained economic recovery, but it has been lagging behind other areas of the economy such as retail sales and consumer confidence.
“Continued job gains through the year are going to be important to continue to move things ahead,” said James Ragan, director of wealth management research at D.A. Davidson.
The S&P 500 index rose 0.2% as of 1:50 p.m. Eastern. The Dow Jones Industrial Average rose 166 points, or 0.5% to 34,397 and the Nasdaq Composite was down 0.3%.
Healthcare stocks fell broadly after news last night that the White House supports waiving intellectual property rights for coronavirus vaccines to help immunize poorer countries faster. But that slide was countered by solid gains from technology companies and banks.
Shares of drugmaker Moderna lost 0.3% after the company reported its first-ever quarterly profit, helped by the company's coronavirus vaccine. The drop was largely tied to the news from the White House, as shares of other drug companies like Pfizer and Merck also fell.
Shares of Johnson & Johnson were relatively unchanged by the news, partly because J&J has other businesses like Band-Aids, the pain reliever Tylenol and its baby products franchise.
Investors remain focused on corporate earnings, with results from Wall Street Journal publisher News Corp after the closing bell, and results from Cigna, Equifax and insurance giant AIG on Friday. Of the S&P 500 companies reporting so far, 84% topped analysts’ expectations, according to FactSet.
Investors’ attention is turning to Friday’s jobs report for April. Economists expect the data to show employers hired 975,000 workers last month as the economy accelerated out of the pandemic and vaccines rolled out nationwide. The unemployment rate is expected to drop to 5.8% from 6%.
There have already been signs that the labor market is improving. The Labor Department said Thursday that the number of Americans who filed for unemployment benefits last week fell to a pandemic low of 498,000. The payroll processing company ADP said Wednesday that private employers hired 742,000 workers last month.
Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report